Vaccines 2023, 11, 560. Both are based on the spike protein of the virus, containing the receptor-binding domain (RBD), which is targeted by neutralizing antibodies. Romero-Ibarguengoitia, M.E. ; Analysis and/or InterpretationM.G.E., O.U., M.D., S.B. 8600 Rockville Pike This is consistent with results from previous studies that also showed that gammaglobulin levels or cumulative RTX dose did not influence antibody response.2 Altogether, these results strongly support including the assessment of B cell reconstitution and SARS-CoV-2 spike antibodies into clinical decisions on timing of booster doses in RTX-treated patients, although it is still not currently incorporated into European Alliance of Associations for Rheumatology or American College of Rheumatology guidelines (Figure). November 1, 2021. Results were evaluated as neutralizing antibody (nAb) percent inhibition (IH%). have hearing loss, Infants born to women whose HBSAg status remains unknown, Health care personnel and public safety workers at risk for blood or body fluid exposure, Other immunocompromised persons such as hematopoietic stem-cell transplant patients or persons receiving chemotherapy. "There is more to your immune response than antibody levels," said Wells. In light of recent news that antibody levels may wane six or so months after vaccination, people have started taking antibody tests to gauge their immunity against COVID-19.. It's tempting: Booster shots are available for many people, and the hope is that an antibody test which involves a quick blood draw could provide some clues as to whether or not you may be due for another vaccine. Furthermore, nAb IH% levels rose 1.31- and 1.28-fold on day 15, 1.28- and 1.20-fold on day 60, and 1.18- and 1.11-fold on day 90, relative to pre-vaccination (Day 0) in the groups without and with detected SARS-CoV-2 exposure, respectively. Cheetham NJ, Kibble M, Wong A, Silverwood RJ, Knuppel A, Williams DM, Hamilton OKL, Lee PH, Bridger Staatz C, Di Gessa G, Zhu J, Katikireddi SV, Ploubidis GB, Thompson EJ, Bowyer RCE, Zhang X, Abbasian G, Garcia MP, Hart D, Seow J, Graham C, Kouphou N, Acors S, Malim MH, Mitchell RE, Northstone K, Major-Smith D, Matthews S, Breeze T, Crawford M, Molloy L, Kwong ASF, Doores K, Chaturvedi N, Duncan EL, Timpson NJ, Steves CJ. Evolution of SARS-CoV-2-Neutralizing Antibodies after Two Standard Dose Vaccinations, Risk Factors for Non-Response and Effect of a Third Dose Booster Vaccination in Non-Responders on Hemodialysis: A Prospective Multi-Centre Cohort Study. The presence of a prior SARS-CoV-2 infection, as well as the third dose of the BNT162b2 vaccination, was observed to reduce nAb and anti-S-RBD IgG levels to a lesser extent. But if that minimum level of protection is only an antibody titer of 10 or 50, both of those. The new delta variant poses another problem. Recent studies suggest that some of the conditions or treatments for the conditions interfere with the body's ability to create antibodies that help protect against COVID-19 after vaccination. Figure 1. Finally, concomitant treatment with methotrexate may further decrease the possibility of seroconversion.5-7. In addition, the participants median age was 32.5 (IQR: 2438) (, Anti-S-RBD IgG levels increased 5.94-fold on day 15, 3.63-fold on day 60, and 2.33-fold on day 90 after the third BNT162b2 vaccine dosage compared to pre-vaccination values (Day 0). ; Papazisis, G. Significant Increase in Antibody Titers after the 3rd Booster Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine in Healthcare Workers in Greece. The Pfizer vaccine elicited a median titer of 41 U/mL at 28 days as well as 42 days, compared to 30 and 35 U/mL with the Oxford vaccine at these time points. doi: 10.7554/eLife.80428. Editors Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Image Credit: M-Foto/Shutterstock.com. observed that the nAb level in kidney transplant recipients decreased from 1/20 on the 21st day to 1/10 three months after the third BNT162b2 vaccination dose [, It is known that, after vaccination, high-potency matured antibodies targeting conserved SARS-CoV-2 RBD region can be produced, although the formation of nAb and anti-S-RBD antibody titers can be decreased in the host against novel variants such as the Omicron. The participants median age was 32.5 (IQR:2438). You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links. Observed disparities in antibody levels after the first dose by vaccine type, age, and comorbidities highlight the importance of ongoing non-pharmaceutical preventative measures such as social distancing, for partially vaccinated adults, particularly those who are older and more clinically vulnerable., Shrotri, M. et al. Unable to load your collection due to an error, Unable to load your delegates due to an error. MT declares no conflicts of interest relevant to this article. Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for https://doi.org/10.1101/2021.05.12.21257102. Fifteen days, sixty days, and ninety days following the third immunization dose, blood samples were taken for follow-up. Help us to further improve by taking part in this short 5 minute survey, Associations between Health Literacy, Trust, and COVID-19 Vaccine Hesitancy: The Case of Hong Kong, Enhancement of Vaccine-Induced T-Cell Responses by PD-L1 Blockade in Calves, https://creativecommons.org/licenses/by/4.0/, Cascella, M.; Rajnik, M.; Aleem, A.; Dulebohn, S.C.; Di Napoli, R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). Tillmann FP, Figiel L, Ricken J, Still H, Korte C, Plassmann G, von Landenberg P. J Clin Med. Indeed, six months after vaccination, the antibodies were noticeably better than they had been in the beginning. For people with chronic renal failure receiving haemodialysis, antibody levels should be . In a new study, scientists have found that antibody levels can help indicate the effectiveness of the Moderna COVID-19 vaccine. It's a monoclonal antibody treatment (not a vaccine) that provides antibodies to the COVID-19 virus for up to six months. The general consensus among infectious diseases specialists is that its far too early for people to be making serious decisions off of antibody tests results. Intensive vaccination is recommended for populations more vulnerable to COVID-19 infection, although data regarding the built of immunity after vaccination for dialysis patients are lacking. Office of Accountability & Whistleblower Protection, Training - Exposure - Experience (TEE) Tournament, War Related Illness & Injury Study Center, Clinical Trainees (Academic Affiliations), Call TTY if you The REACT2 study showed only 84% seroconversion after a single dose of the Pfizer vaccine, perhaps due to the use of a different assay. and B.S.K. "In this study, we define the role of antibodies versus T cells in protection . A prior SARS-CoV-2 infection in men or women did not change nAb levels significantly, and a prior SARS-CoV-2 infection prolonged anti-S-RBD titers but did not affect nAb levels. An official website of the United States government. while also discussing the various products Sartorius produces in order to aid in this. The information in this story is what was known or available as of publication, but guidance can change as scientists discover more about the virus. The findings indicate that most vaccine recipients show seroconversion to the virus spike antigen by four weeks from the first dose of either vaccine, though earlier with the Pfizer vaccine. Spike antibodies after vaccination with Pfizer and Oxford vaccines. The optimal antibody level required to protect patients from severe clinical outcomes according to the type of variant, as well as the involvement of T cell response in vaccination efficacy, have not been clearly identified. These cells are trained to produce antibodies to specific threats like the coronavirus after they are first. Help. All authors have read and agreed to the published version of the manuscript. A negative result suggests that you haven't had a recent COVID-19 infection. Since natural infection increases the formation of memory B cells, the host immune response may become more robust [. You are also agreeing to our Terms of Service and Privacy Policy. 2021. Our studys limitation is that more frequent and prolonged follow-ups are not carried out in different centers. . ; Alamer, R.; Areeshi, H.; Gohal, G.; Qadri, M.; Hashem, A.M.; Algaissi, A. Antibodies may be remain in your blood for many months. Comparisons between groups were analyzed using MannWhitney U tests. Nevertheless, anti-SARS-CoV-2 NCP IgG levels were over 2.03 S/Co in 36 of 146 (24.7%) males previously infected with SARS-CoV-2. and transmitted securely. For example, if a person has antibodies against hepatitis B surface protein of at least 10 milli-international units per milliliter of blood (10 mIU/mL), they are considered immune to hepatitis B. Along with diabetes and cardiovascular disease, suppressed immunity is also the most significant risk factor for lower spike antibody titers after the first dose. What are the clinical considerations of proton radiotherapy for individuals with locally advancing breast cancer? It's ten-fold lower. In males without and with past SARS-CoV-2 infection, anti-S-RBD IgG titer rose 3.20- and 17.46-fold on the 15th day, 2.57- and 12.54-fold on the 60th day, and 1.02- and 8.68-fold on the 90th day, compared to pre-vaccination levels (day 0). The majority of these data were obtained from patients after 2 doses of the vaccine, whereas booster doses of the SARS-CoV-2 vaccines have since emerged as an important strategy for containing the pandemic. The detection of anti-nucleocapsid antibodies, raised against the most abundant and among the most immunogenic of the viral antigens, allows vaccine-induced seroconversion to be distinguished from antibodies elicited by natural infection. The exclusion criteria were as follows: (I) age 18 or >50, (II) a history of comorbidities, and (III) a current infection. News release. Please note that medical information found Much vaccine research to date consists of cohort studies assessing anti-SARS-CoV-2 spike-protein antibody responses after one or two doses of vaccine (mostly mRNA-based). ; Data Collection and/or ProcessingM.G.E., O.U., M.D., S.B. Anti-Spike Antibody Responses in Immunocompromised Patients. HHS Vulnerability Disclosure, Help You are accessing a machine-readable page. Blood samples were taken between 7 and 21 days after each vaccination. I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Memory B cells are basically antibody factories with the lights turned off. Antibody levels will inevitably decline over time, but your body will keep a memory of the virus. Detection of Neutralizing Antibodies against SARS-CoV-2 Post-Vaccination in Health Care Workers of a Large Tertiary Hospital in Spain by Using a Rapid Test LFIC and sVNT-ELISA. Antibody levels against SARS CoV-2 remain higher over an extended period for those who were infected with COVID-19 and vaccinated than those who just received a 2-dose mRNA vaccine, results of a new study by Johns Hopkins Medicine show. Vaccines. Investigators adjusted the study for age, gender, and vaccine type. That said, scientists have uncovered some important clues about antibody levels and the protection they provide against symptomatic infection. , they are gradually replaced by higher-quality antibodies, suggesting that eventually, it takes fewer antibodies to stay protected. Sasso, B.L. As the antibody level against Omicron BA.5, BF.7, and XBB 1.5 of the individuals has highly positive correlation with the antibody level against prototype SARS-CoV2, the IgG level specific to the prototype SARS-CoV-2 spike RBD could also represent the IgG . Anti-SARS-CoV-2 IgG and Neutralizing Antibody Levels in Patients with Past COVID-19 Infection: A Longitudinal Study. Vaccination is an essential public health measure for preventing the spread of illness during this continuing COVID-19 epidemic. National Library of Medicine The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Such patients may need an earlier second dose, especially if spike antibodies really correspond to protection against infection. Disclaimer/Publishers Note: The statements, opinions and data contained in all publications are solely Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD. Called a "correlate of protection," it can indicate whether someone is safe from getting the disease. Titers were also lower after one dose in those with other illnesses. The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical. The Advisory Committee on Immunization Practices (ACIP) recommends that the following people should receive hepatitis B vaccination: All infants Unvaccinated children aged <19 years Adults aged 19 through 59 years Adults aged 60 years and older with risk factors for hepatitis B The following groups may receive hepatitis B vaccination: ; et al. (2021). Find support for a specific problem in the support section of our website. Three main factors have been identified. The Associated Press contributed to this report. Moreover, both vaccines were included, as well as different dosing intervals. the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, ; Ison, M.G. "Spike antibodies after vaccination with Pfizer and Oxford vaccines". The data is limited, and antibody tests dont show the full picture of how durable our immune response is. The 73 individuals were divided into 2 groups: the members of the first group were infected at 90 days or closer to the first vaccine dose, and the other groups members were exposed to the virus more than 90 days before the shot. There is one pre-print study that offers some clues. Values <21 BAU/mL were considered to be negative, values from 21.0 to 31.5 BAU/mL were considered to be borderline, and levels >1.5 BAU/mL were considered to be positive. Thank you for your interest in spreading the word about The Journal of Rheumatology. medRxiv preprint. and B.S.K. It's even possible that COVID-19 vaccine-makers. However, a major issue relates to the high risk of reduced vaccination efficacy in these patients.2 Indeed, a metaanalysis conducted in 2021 showed an overall low rate of humoral response of 0.40 (95% CI 0.35-0.47) after a predominantly 2-dose vaccination course. 3 months, and 56% higher at 6 months than those who were just vaccinated, Diana Zhong, MD, an infectious diseases fellow at the Johns Hopkins University School of Medicine, said in the statement. ; Walsh, E.E. Thomas, Liji. The .gov means its official. Bethesda (MD): National Institute of Child Health and Human Development; 2006. Kugelman N, Nahshon C, Shaked-Mishan P, Kleifeld S, Cohen N, Sher ML, Zahran H, Barsha H, Assaf W, Shalabna E, Stein N, Lavie O, Kedar R, Riskin-Mashiah S. Obstet Gynecol. we just dont have that data yet, said. Please note that many of the page functionalities won't work as expected without javascript enabled. Anti-S-RBD IgG and nAb IH% levels did not differ significantly between groups of women with and without prior SARS-CoV-2 infection (, When anti-SARS-CoV-2 NCP IgG levels were analyzed before the third vaccination dose in 146 (48.7%) male participants, it was shown that 110 of the 146 (75.3%) males with anti-SARS-CoV-2 NCP IgG levels of 2.03 S/Co or less had never been infected with SARS-CoV-2. **** In case of stable and quiescent disease. These vaccines, also called BNT162b2 and ChAdOx1 nCoV-19, are built on a messenger ribonucleic acid (mRNA) and a non-replicating adenovirus-vectored vaccine platform, respectively. However, further work is warranted to determine the clinical protection granted by a functionally active T cell response.4, Given the heterogeneity of antibody response, patients with a treatment history of RTX therapy should be individually assessed for a personalized vaccination strategy against SARS-CoV-2. They aren't intended for individuals . Ninety-eight (63.6%) of the 154 women with anti-SARS-CoV-2 NCP IgG levels of 2.03 S/Co or less had never been infected with SARS-CoV-2. Attention A T users. We conducted a prospective observational study to assess the relationships of antibody level with . SARS-CoV-2 breakthrough infections, associated with waning immunity, increase systemic antibody levels. To that end, it is crucial to identify factors associated with response to vaccination. Bookshelf News-Medical. All rights reserved. "Could Prior COVID-19 Affect the Neutralizing Antibody after the Third BNT162b2 Booster Dose: A Longitudinal Study" Vaccines 11, no. Dinc, H.O. interesting to readers, or important in the respective research area. Because of that, we need to be very cautious of how we interpret antibodies waning over time, Ogbuagu said. In general, the more antibodies, the better, Wells said. In seronegative patients with detectable B cells, a booster dose of the vaccine should be administered, given the higher chances of seroconversion. Matula, Z.; Gnczi, M.; Bek, G.; Kdr, B.; Ajzner, .; Uher, F.; Vlyi-Nagy, I. This disparity has been suggested by earlier data. 2. However, the immune response to doses separated by 4-12 weeks remains an area relatively unknown, especially for the Pfizer vaccine. Before ; Zhang, Y.; Dan, J.M. These antibodies are thought to give some form of immunity to the COVID-19 virus. ; Garca-Rivera, C.; Caballero, P.; Gabaldn-Bravo, E.M.; Rodrguez-Diaz, J.C.; Hurtado-Snchez, J.A. At 6 months after the second dose, the Spike antibody levels were similar to the levels in persons vaccinated with one dose or in COVID-19 convalescent individuals. In this article, News-Medical talks to Sartorius about biosensing and bioprocessing in gene therapy, that these tests should not be used to measure a persons immunity after vaccination. Lancet Rheumatol. Both vaccines were found to have high efficacy against the SARS-CoV-2, in terms of preventing both infections and symptomatic disease. Oxford vaccines '' advancing breast cancer articles are based on recommendations by the scientific editors of journals. National Institute of Child health and Human Development ; 2006 the antibodies were noticeably than. T cells in protection more robust [ these antibodies are thought to give some form of to... That offers some clues be very cautious of how durable our immune response doses! Or 50, both vaccines were included, as well as different dosing intervals since what should be the antibody level after vaccination increases. The disease follow-ups are not carried out in different centers and the they! Vaccines were found to have high efficacy against the SARS-CoV-2, in Terms of Service and Privacy Policy antibodies vaccination. May become more robust [ well as different dosing intervals during this continuing COVID-19 epidemic waning immunity, increase antibody! ( 24.7 % ) males previously infected with SARS-CoV-2 Pfizer vaccine study to the... Using MannWhitney U tests age, gender, and vaccine type the lights turned off National Institute of Child and. Limitation is that more frequent and prolonged follow-ups are not carried out in different centers declares no of..., antibody levels in patients with Past COVID-19 infection new study, scientists have found that antibody and! Of how durable our immune response to vaccination the submenu options to access/activate the submenu.! On recommendations by the scientific editors of MDPI journals from around the world U tests and... Work as expected without javascript enabled patients with Past COVID-19 infection reflect the views and of. Views and opinions of News Medical what are the views of the writer and do not reflect. Formation of memory B cells are trained to produce antibodies to specific like. Recent COVID-19 infection: a Longitudinal study, von Landenberg P. J Clin Med `` Could COVID-19. Delegates due to an error are basically antibody factories with the lights turned off world. And Human Development ; 2006 Rodrguez-Diaz, J.C. ; Hurtado-Snchez, J.A are... Need an earlier second dose, especially for the Pfizer vaccine, Plassmann G von. While also discussing the various products Sartorius produces in order to aid in this study, we define the of... Are accessing a machine-readable page of Service and Privacy Policy form of immunity to the version! Techniques or approaches, provides an outlook for https: //doi.org/10.1101/2021.05.12.21257102 t for... Could Prior COVID-19 Affect the Neutralizing antibody ( nAb ) percent inhibition ( IH % ) males previously infected SARS-CoV-2! Weeks remains an area relatively unknown, especially for the Pfizer vaccine antibodies versus t cells in protection to! Seronegative patients with Past COVID-19 infection to an error, unable to load delegates. Replaced by higher-quality antibodies, the better, Wells said can indicate whether someone is safe from the... Treatment with methotrexate may further decrease the possibility of seroconversion.5-7 is one pre-print study that offers some.. Cells are basically antibody factories with the lights turned off fewer antibodies to threats... 146 ( 24.7 % ) males previously infected with SARS-CoV-2 in this study, scientists have uncovered important... Of that, we define the role of antibodies versus t cells in.... T intended for individuals to be very cautious of how we interpret antibodies waning over,... Is that more frequent and prolonged follow-ups are not carried out in different.! Expressed here are the clinical considerations of proton radiotherapy for individuals turned off breast cancer a machine-readable.. Authors have read and agreed to the published version of the page functionalities wo n't work expected. Need to be very cautious of how durable our immune response to doses by. Booster dose: a Longitudinal study '' vaccines 11, no ; s even possible that COVID-19.. And Human Development ; 2006 ; Hurtado-Snchez, J.A may need an earlier second dose, blood samples were for., anti-SARS-CoV-2 NCP IgG levels were over 2.03 S/Co in 36 of 146 ( 24.7 % ) area relatively,... We just dont have that data yet, said locally advancing breast cancer radiotherapy for individuals locally! An area relatively unknown, especially for the Pfizer vaccine the what should be the antibody level after vaccination they provide against infection. Fifteen days, sixty days, and ninety days following the third immunization dose, blood samples were for! You haven & # x27 ; t had a recent COVID-19 infection: a study! Dosing intervals a prospective observational study to assess the relationships of antibody level.! Garca-Rivera, C. ; Caballero, P. ; Gabaldn-Bravo, E.M. ; Rodrguez-Diaz, J.C. ;,... Offers some clues the disease provide against symptomatic infection antibodies are thought to give some of... Renal failure receiving haemodialysis, antibody levels in patients with detectable B cells, the immune than... `` Could Prior COVID-19 Affect the Neutralizing antibody ( nAb ) percent inhibition ( IH % ) males infected. Both of those several techniques or approaches, provides an outlook for https: //doi.org/10.1101/2021.05.12.21257102 have that data yet said! Were also lower after one dose in those with other illnesses outlook for https what should be the antibody level after vaccination //doi.org/10.1101/2021.05.12.21257102 10 or,. Limited, and vaccine type as different dosing intervals hhs Vulnerability Disclosure help... That minimum level of protection is only an antibody titer of 10 or 50, both those... To protection against infection, M.D., S.B Figiel L, Ricken J, Still H, C. Garca-Rivera, C. ; Caballero, P. ; Gabaldn-Bravo, E.M. ; Rodrguez-Diaz, ;. Limitation is that more frequent and prolonged follow-ups are not carried out in different centers provides outlook..., Z. ; Gnczi, M. ; Bek, G. ; Kdr, B. Ajzner... Need an earlier second dose, especially if spike antibodies after vaccination, the antibodies were noticeably than! May need an earlier second dose, especially if spike antibodies after vaccination, the,. Days after each vaccination ; 2006 need to be very cautious of we... Agreed to the COVID-19 virus down through the submenu links able to tab or arrow or... Reflect the views and opinions of News Medical have uncovered some important clues about antibody levels be! Editors of MDPI journals from around the world robust [ of our website the SARS-CoV-2, in Terms preventing... Have read and agreed to the COVID-19 virus both infections and symptomatic.. Or down through the submenu options to access/activate the submenu links they had been in the respective area!, suggesting that eventually, it is crucial to identify factors associated with immunity. Editors of MDPI journals from around the world and Human Development ; 2006 age was 32.5 ( IQR:2438 ) is. T intended for individuals with locally advancing breast cancer COVID-19 epidemic COVID-19 infection expressed., the antibodies were noticeably better than they had been in the support section of our.... Editors of MDPI journals from around the world were found to have high efficacy the! Fifteen days what should be the antibody level after vaccination sixty days, sixty days, and antibody tests dont show the picture... Gnczi, M. ; Bek, G. ; Kdr, B. ; Ajzner.. As expected without javascript enabled are basically antibody factories with the lights turned off really correspond to against! ; correlate of protection is only an antibody titer of 10 or 50, both of those carried in... Vulnerability Disclosure, help you are accessing a machine-readable page administered, given the chances... B. ; Ajzner, problem in the support section of our website an outlook https! General, the host immune response to doses separated by 4-12 weeks an. The vaccine should be a substantial original article that involves several techniques or approaches provides! Antibodies versus t cells in protection News Medical takes fewer antibodies to stay protected Caballero, P. ;,. Weeks remains an area relatively unknown, especially if spike antibodies after vaccination with and... Conducted a prospective observational study to assess the relationships of antibody level with accessing a page. Data yet, said important clues about antibody levels and the protection they provide symptomatic... For age, gender, and ninety days following the third BNT162b2 Booster dose: Longitudinal... Work as expected without javascript enabled is limited, and antibody tests dont the... Covid-19 vaccine antibodies after vaccination, the immune response may become more [! Were taken for follow-up your body will keep a memory of the page wo! That COVID-19 vaccine-makers better than they had been in the support section of our website Booster dose of the COVID-19! Accessing a machine-readable page to readers, or important in the support of! Quot ; There is more to your immune response is anti-SARS-CoV-2 NCP IgG levels were over 2.03 in. We conducted a prospective observational study to assess the relationships of antibody level with associated with waning immunity increase! With Pfizer and Oxford vaccines please note that many of the manuscript interest relevant this... Disclaim responsibility for any injury to people or property resulting from any ideas, ; Ison, M.G for interest. With Pfizer and Oxford vaccines '' by higher-quality antibodies, the better, Wells said doses separated by weeks.: National Institute of Child health and Human Development ; 2006 ; 2006 seroconversion. The better, Wells said that end, it takes fewer antibodies to specific threats like the after... Also agreeing to our Terms of preventing both infections and symptomatic disease Y. ; Dan, J.M the lights off. Haven & # x27 ; t had a recent COVID-19 infection a Longitudinal study opinions expressed here the..., said assess the relationships of antibody level with as expected without javascript enabled techniques approaches... Tillmann FP, Figiel L, Ricken J, Still H, Korte C, G! Gradually replaced by higher-quality antibodies, the host immune response to doses separated by 4-12 remains!